Sisi Jing
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Plasma proteomic trajectories before the onset of neurodegenerative diseases.
Journal: Neurodegenerative disease management
Published: March 20, 2026
Predictors of Quality of Life in Myasthenia Gravis Patients from Southwestern China: Validation of Clinical and Socioenvironmental Determinants.
Journal: Neuroepidemiology
Published: July 25, 2025
Monocyte-macrophage SAMHD1 alleviates EAMG by modulating the cGAS-STING pathway.
Journal: Journal of neuroinflammation
Published: June 13, 2025
Association of regional adiposity distribution with risk of autoimmune diseases.
Journal: Clinical rheumatology
Published: July 18, 2024
A predictive nomogram for short-term outcomes of myasthenia gravis patients treated with low-dose rituximab.
Journal: CNS neuroscience & therapeutics
Published: October 11, 2023
Berberine attenuates experimental autoimmune myasthenia gravis via rebalancing the T cell subsets.
Journal: Journal of neuroimmunology
Published: May 08, 2021
A Case Report of Adult-Onset Alexander Disease with a Tumor-Like Lesion in the Lateral Ventricle.
Journal: Case reports in neurology
Published: March 02, 2021
Low-dose rituximab lowers serum Exosomal miR-150-5p in AChR-positive refractory myasthenia gravis patients.
Journal: Journal of neuroimmunology
Published: June 17, 2020
Low-dose rituximab every 6 months for the treatment of acetylcholine receptor-positive refractory generalized myasthenia gravis.
Journal: Muscle & nerve
Published: May 01, 2019
Effect of low-dose rituximab treatment on T- and B-cell lymphocyte imbalance in refractory myasthenia gravis.
Journal: Journal of neuroimmunology
Published: February 17, 2019
Responsiveness to low-dose rituximab in refractory generalized myasthenia gravis.
Journal: Journal of neuroimmunology
Published: February 19, 2017
Last Updated: 09/26/2026